Cytidine deamination and resistance to retroviral infection: Towards a structural understanding of the APOBEC proteins

Virology

Volumn 334, Issue 2, 2005, Pages 147-153

  Huthoff, Hendrik ^a   Malim, Michael H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

APOBEC proteins; Cytidine deamination; Retroviral infection

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE; CYTIDINE; CYTIDINE DEAMINASE; POLYPEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; CONTROLLED STUDY; DEAMINATION; ENZYME INDUCTION; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RESISTANCE; MOLECULAR MODEL; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; RETROVIRUS; SHORT SURVEY; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURE ANALYSIS; VIRUS INFECTION;

SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; VERTEBRATA;

EID: 15244355533     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.01.038     Document Type: Short Survey

References (60)

1. V. Barreto, B. Reina-San-Martin, A.R. Ramiro, K.M. McBride, and M.C. Nussenzweig C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion Mol. Cell 12 2003 501 508
2. L. Betts, S. Xiang, S.A. Short, R. Wolfenden, and C.W. Carter Jr. Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex J. Mol. Biol. 235 1994 635 656
3. K.N. Bishop, R.K. Holmes, A.M. Sheehy, N.O. Davidson, S.J. Cho, and M.H. Malim Cytidine deamination of retroviral DNA by diverse APOBEC proteins Curr. Biol. 14 2004 1392 1396
4. K.N. Bishop, R.K. Holmes, A.M. Sheehy, and M.H. Malim APOBEC-mediated editing of viral RNA Science 305 2004 645
5. H.P. Bogerd, B.P. Doehle, H.L. Wiegand, and B.R. Cullen A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor Proc. Natl. Acad. Sci. U.S.A. 101 2004 3770 3774
6. R. Bransteitter, P. Pham, P. Calabrese, and M.F. Goodman Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase J. Biol. Chem. 279 2004 51612 51621
7. S.S. Brar, M. Watson, and M. Diaz Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks J. Biol. Chem. 279 2004 26395 26401
8. S.J. Chung, J.C. Fromme, and G.L. Verdine Structure of human cytidine deaminase bound to a potent inhibitor J. Med. Chem. 48 2005 658 660
9. S.G. Conticello, R.S. Harris, and M.S. Neuberger The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G Curr. Biol. 13 2003 2009 2013
10. S.G. Conticello, C.J. Thomas, S.K. Petersen-Mahrt, and M.S. Neuberger Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases Mol. Biol. Evol. 22 2005 367 377
11. N.C. Gaddis, A.M. Sheehy, K.M. Ahmad, C.M. Swanson, K.N. Bishop, B.E. Beer, P.A. Marx, F. Gao, F. Bibollet-Ruche, B.H. Hahn, and M.H. Malim Further investigation of simian immunodeficiency virus Vif function in human cells J. Virol. 78 2004 12041 12046
12. R.S. Harris, and M.T. Liddament Retroviral restriction by APOBEC proteins Nat. Rev., Immunol. 4 2004 868 877
13. R.S. Harris, K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen-Mahrt, I.N. Watt, M.S. Neuberger, and M.H. Malim DNA deamination mediates innate immunity to retroviral infection Cell 113 2003 803 809
14. S. Ito, H. Nagaoka, R. Shinkura, N. Begum, M. Muramatsu, M. Nakata, and T. Honjo Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1 Proc. Natl. Acad. Sci. U.S.A. 101 2004 1975 1980
15. A. Jarmuz, A. Chester, J. Bayliss, J. Gisbourne, I. Dunham, J. Scott, and N. Navaratnam An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 Genomics 79 2002 285 296
16. E. Johansson, N. Mejlhede, J. Neuhard, and S. Larsen Crystal structure of the tetrameric cytidine deaminase from Bacillus subtilis at 2.0 A resolution Biochemistry 41 2002 2563 2570
17. W. Kabsch, and C. Sander Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features Biopolymers 22 1983 2577 2637
18. R. Karchin, M. Cline, Y. Mandel-Gutfreund, and K. Karplus Hidden Markov models that use predicted local structure for fold recognition: alphabets of backbone geometry Proteins 51 2003 504 514
19. K. Karplus, R. Karchin, C. Barrett, S. Tu, M. Cline, M. Diekhans, L. Grate, J. Casper, and R. Hughey What is the value added by human intervention in protein structure prediction? Proteins, Suppl. 5 2001 86 91
20. K. Karplus, R. Karchin, J. Draper, J. Casper, Y. Mandel-Gutfreund, M. Diekhans, and R. Hughey Combining local-structure, fold-recognition, and new fold methods for protein structure prediction Proteins 53 Suppl. 6 2003 491 496
21. D. Lecossier, F. Bouchonnet, F. Clavel, and A.J. Hance Hypermutation of HIV-1 DNA in the absence of the Vif protein Science 300 2003 1112
22. G.S. Lee, V.L. Brandt, and D.B. Roth B cell development leads off with a base hit: dU:dG mismatches in class switching and hypermutation Mol. Cell 16 2004 505 508
23. W. Liao, S.H. Hong, B.H. Chan, F.B. Rudolph, S.C. Clark, and L. Chan APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family Biochem. Biophys. Res. Commun. 260 1999 398 404
24. M.T. Liddament, W.L. Brown, A.J. Schumacher, and R.S. Harris APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo Curr. Biol. 14 2004 1385 1391
25. B. Liu, X. Yu, K. Luo, Y. Yu, and X.F. Yu Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G J. Virol. 78 2004 2072 2081
26. A.J. MacGinnitie, S. Anant, and N.O. Davidson Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity J. Biol. Chem. 270 1995 14768 14775
27. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 2003 99 103
28. B. Mangeat, P. Turelli, S. Liao, and D. Trono A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action J. Biol. Chem. 279 2004 14481 14483
29. R. Mariani, D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N.R. Landau Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114 2003 21 31
30. M. Marin, K.M. Rose, S.L. Kozak, and D. Kabat HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat. Med. 9 2003 1398 1403
31. A. Mehle, J. Goncalves, M. Santa-Marta, M. McPike, and D. Gabuzda Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation Genes Dev. 18 2004 2861 2866
32. N. Navaratnam, S. Bhattacharya, T. Fujino, D. Patel, A.L. Jarmuz, and J. Scott Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site Cell 81 1995 187 195
33. N. Navaratnam, T. Fujino, J. Bayliss, A. Jarmuz, A. How, N. Richardson, A. Somasekaram, S. Bhattacharya, C. Carter, and J. Scott Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition J. Mol. Biol. 275 1998 695 714
34. E.N. Newman, R.K. Holmes, H.M. Craig, K.C. Klein, J.R. Lingappa, M.H. Malim, and A.M. Sheehy Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity Curr. Biol. 15 2005 166 170
35. A.R. Ramiro, P. Stavropoulos, M. Jankovic, and M.C. Nussenzweig Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand Nat. Immunol. 4 2003 452 456
36. C. Rosler, J. Kock, M.H. Malim, H.E. Blum, and W.F. von Comment on "Inhibition of hepatitis B virus replication by APOBEC3G" Science 305 2004 1403
37. B. Schrofelbauer, D. Chen, and N.R. Landau A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif) Proc. Natl. Acad. Sci. U.S.A. 101 2004 3927 3932
38. A.M. Sheehy, N.C. Gaddis, J.D. Choi, and M.H. Malim Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 418 2002 646 650
39. A.M. Sheehy, N.C. Gaddis, and M.H. Malim The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat. Med. 9 2003 1404 1407
40. K. Shindo, A. Takaori-Kondo, M. Kobayashi, A. Abudu, K. Fukunaga, and T. Uchiyama The enzymatic activity of CEM15/APOBEC-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity J. Biol. Chem. 278 2003 44412 44416
41. R. Shinkura, S. Ito, N.A. Begum, H. Nagaoka, M. Muramatsu, K. Kinoshita, Y. Sakakibara, H. Hijikata, and T. Honjo Separate domains of AID are required for somatic hypermutation and class-switch recombination Nat. Immunol. 5 2004 707 712
42. J.H. Simon, and M.H. Malim The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes J. Virol. 70 1996 5297 5305
43. K. Stopak, N.C. de, W. Yonemoto, and W.C. Greene HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability Mol. Cell 12 2003 591 601
44. V.T. Ta, H. Nagaoka, N. Catalan, A. Durandy, A. Fischer, K. Imai, S. Nonoyama, J. Tashiro, M. Ikegawa, S. Ito, K. Kinoshita, M. Muramatsu, and T. Honjo AID mutant analyses indicate requirement for class-switch-specific cofactors Nat. Immunol. 4 2003 843 848
45. B. Teng, C.F. Burant, and N.O. Davidson Molecular cloning of an apolipoprotein B messenger RNA editing protein Science 260 1993 1816 1819
46. B.B. Teng, S. Ochsner, Q. Zhang, K.V. Soman, P.P. Lau, and L. Chan Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1) structure-function relationships of RNA editing and dimerization J. Lipid Res. 40 1999 623 635
47. P. Turelli, B. Mangeat, S. Jost, S. Vianin, and D. Trono Inhibition of hepatitis B virus replication by APOBEC3G Science 303 2004 1829
48. J.E. Wedekind, G.S. Dance, M.P. Sowden, and H.C. Smith Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business Trends Genet. 19 2003 207 216
49. H.L. Wiegand, B.P. Doehle, H.P. Bogerd, and B.R. Cullen A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins EMBO J. 23 2004 2451 2458
50. K. Xie, M.P. Sowden, G.S. Dance, A.T. Torelli, H.C. Smith, and J.E. Wedekind The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1 Proc. Natl. Acad. Sci. U.S.A. 101 2004 8114 8119
51. H. Xu, E.S. Svarovskaia, R. Barr, Y. Zhang, M.A. Khan, K. Strebel, and V.K. Pathak A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion Proc. Natl. Acad. Sci. U.S.A. 101 2004 5652 5657
52. S. Yamanaka, K.S. Poksay, M.E. Balestra, G.Q. Zeng, and T.L. Innerarity Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed J. Biol. Chem. 269 1994 21725 21734
53. Y. Yang, Y. Yang, and H.C. Smith Multiple protein domains determine the cell type-specific nuclear distribution of the catalytic subunit required for apolipoprotein B mRNA editing Proc. Natl. Acad. Sci. U.S.A. 94 1997 13075 13080
54. Y. Yang, M.P. Sowden, Y. Yang, and H.C. Smith Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA Exp. Cell Res. 267 2001 153 164
55. X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.F. Yu Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 302 2003 1056 1060
56. Q. Yu, D. Chen, R. Konig, R. Mariani, D. Unutmaz, and N.R. Landau APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication J. Biol. Chem. 279 2004 53379 53386
57. Y. Yu, Z. Xiao, E.S. Ehrlich, X. Yu, and X.F. Yu Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines Genes Dev. 18 2004 2867 2872
58. J. Zaim, and A.M. Kierzek Domain organization of activation-induced cytidine deaminase Nat. Immunol. 4 2003 1153
59. H. Zhang, B. Yang, R.J. Pomerantz, C. Zhang, S.C. Arunachalam, and L. Gao The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424 2003 94 98
60. Y.H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata, and B.M. Peterlin Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication J. Virol. 78 2004 6073 6076